Stephen Gallo is a Development Associate III in Process Development at AbbVie since February 2024, focusing on ADC drug substance and product development while collaborating with external vendors. Prior to AbbVie, Gallo held the same title at ImmunoGen, Inc. from November 2022 to February 2024, supporting similar development activities. Earlier experience includes roles as Manufacturing Technician and Scientist at LSNE Contract Manufacturing from April 2019 to October 2020. Gallo is pursuing a Master of Business Administration with a concentration in Operations and Supply Chain Management at Southern New Hampshire University, having previously earned a Bachelor of Science in Human Biology from the University of Southern Maine.
This person is not in the org chart
This person is not in any teams
This person is not in any offices